XM does not provide services to residents of the United States of America.

UK competition regulator to investigate vets market



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-UK competition regulator to investigate vets market</title></head><body>

Adds company statement, share movement in paragraphs 7-9

May 23 (Reuters) -Britain's veterinary sector will face a formal market investigation, after an initial review raised concerns about pricing and competition, the country's competition regulator said on Thursday.

Concerns that pet owners might not be getting a good deal on veterinary services prompted the Competition and Markets Authority (CMA) to start looking last September into Britain's veterinary market, which is estimated to be worth more than 2 billion pounds ($2.54 billion).

In March, the regulator published its review, flagging several concerns including pet owners potentially overpaying for medicines, concentrated local markets and large companies potentially acting in ways that reduce choice and competition.

An inquiry group made up of independent experts will oversee the investigation, CMA said in a statement.

Britain's six largest veterinary groups are CVS Group CVSG.L, IVC, Linnaeus, Medivet, Pets at Home PETSP.L and VetPartners. Since 2013, 30% of the 5,000 vet practices in Britain have been bought by these firms, the CMA said in March.

CVS said on Thursday it "will continue to proactively support the CMA through this market investigation".

"We will continue to fully cooperate with the CMA to ensure our unique and pro-competitive business model of locally-owned vet practices is fully understood," a Pets At Home spokesperson said.

Those vet practices are led by individual vets who choose their own pricing, products and services, Pets At Home has said.

Shares in the company were down 3.3%, while CVS was up 3.2%.

"While we're aware of acute staff shortages and difficult working conditions for vets, we consider a formal market investigation is essential to ensure good outcomes for the millions of pet owners in the UK as well as professionals working in the sector," said CMA Chief Executive Sarah Cardell.


($1 = 0.7860 pounds)



Reporting by Eva Mathews in Bengaluru; Editing by Rashmi Aich, Alexandra Hudson

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.